139 related articles for article (PubMed ID: 27701389)
21. A prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization.
Ogasawara S; Chiba T; Ooka Y; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Azemoto R; Shinozaki M; Yoshikawa M; Yokosuka O
PLoS One; 2015; 10(4):e0125244. PubMed ID: 25919025
[TBL] [Abstract][Full Text] [Related]
22. A prognostic scoring system for patients with multiple hepatocellular carcinomas treated by hepatectomy.
Yang P; Wu D; Xia Y; Li J; Wang K; Yan Z; Shi L; Lau WY; Wu M; Shen F
Ann Surg Oncol; 2015 Mar; 22(3):826-33. PubMed ID: 25216602
[TBL] [Abstract][Full Text] [Related]
23. Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma.
Renner P; Schuhbaum J; Kroemer A; Zeman F; Loss M; Lang SA; Geissler EK; Schlitt HJ; Farkas SA
Langenbecks Arch Surg; 2016 Feb; 401(1):43-53. PubMed ID: 26627084
[TBL] [Abstract][Full Text] [Related]
24. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
[TBL] [Abstract][Full Text] [Related]
25. Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis.
Torzilli G; Donadon M; Marconi M; Palmisano A; Del Fabbro D; Spinelli A; Botea F; Montorsi M
Arch Surg; 2008 Nov; 143(11):1082-90. PubMed ID: 19015467
[TBL] [Abstract][Full Text] [Related]
26. Significance of incorporation of model for end-stage liver disease score with TNM staging in patients with hepatocellular carcinoma undergoing hepatic resection.
Ling CH; Chau GY; Hsia CY; King KL
Hepatogastroenterology; 2013; 60(125):1142-7. PubMed ID: 23803377
[TBL] [Abstract][Full Text] [Related]
27. Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma.
Kondo K; Chijiiwa K; Nagano M; Hiyoshi M; Kai M; Maehara N; Ohuchida J; Nakao H; Ohkuwa Y
Hepatogastroenterology; 2007; 54(77):1534-8. PubMed ID: 17708292
[TBL] [Abstract][Full Text] [Related]
28. Artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma.
Qiao G; Li J; Huang A; Yan Z; Lau WY; Shen F
J Gastroenterol Hepatol; 2014 Dec; 29(12):2014-20. PubMed ID: 24989634
[TBL] [Abstract][Full Text] [Related]
29. How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma.
Hucke F; Pinter M; Graziadei I; Bota S; Vogel W; Müller C; Heinzl H; Waneck F; Trauner M; Peck-Radosavljevic M; Sieghart W
J Hepatol; 2014 Dec; 61(6):1287-96. PubMed ID: 25016222
[TBL] [Abstract][Full Text] [Related]
30. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.
Shim JH; Jun MJ; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC
Ann Surg; 2015 May; 261(5):939-46. PubMed ID: 24950276
[TBL] [Abstract][Full Text] [Related]
31. Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.
Kim H; Ahn SW; Hong SK; Yoon KC; Kim HS; Choi YR; Lee HW; Yi NJ; Lee KW; Suh KS;
Br J Surg; 2017 Jul; 104(8):1045-1052. PubMed ID: 28480964
[TBL] [Abstract][Full Text] [Related]
32. A Modified Model for Assessment for Retreatment with Transarterial Chemoembolization in Chinese Hepatocellular Carcinoma Patients.
Chen L; Ni CF; Chen SX; Cao JM; Zhu HD; Guo JH; Zhu GY; Zhong BY; Ding W; He SC; Deng G; Teng GJ
J Vasc Interv Radiol; 2016 Sep; 27(9):1288-1297. PubMed ID: 27013402
[TBL] [Abstract][Full Text] [Related]
33. Prognostic influence of spontaneous tumor rupture on hepatocellular carcinoma after interval hepatectomy.
Chan AC; Dai JW; Chok KS; Cheung TT; Lo CM
Surgery; 2016 Feb; 159(2):409-17. PubMed ID: 26294087
[TBL] [Abstract][Full Text] [Related]
34. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
[TBL] [Abstract][Full Text] [Related]
35. Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma.
Liu W; Wang K; Bao Q; Sun Y; Xing BC
World J Surg Oncol; 2016 Mar; 14():62. PubMed ID: 26936459
[TBL] [Abstract][Full Text] [Related]
36. Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score.
Park Y; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Park YE; Park JH; Lee YI; Yun HR; Han KH
Liver Int; 2016 Jan; 36(1):100-7. PubMed ID: 26013186
[TBL] [Abstract][Full Text] [Related]
37. Survival benefit of hepatic resection for hepatocellular carcinoma beyond the Barcelona Clinic Liver Cancer classification.
Furukawa K; Shiba H; Horiuchi T; Shirai Y; Haruki K; Fujiwara Y; Sakamoto T; Gocho T; Yanaga K
J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):199-205. PubMed ID: 28160422
[TBL] [Abstract][Full Text] [Related]
38. An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy.
Tokumitsu Y; Tamesa T; Matsukuma S; Hashimoto N; Maeda Y; Tokuhisa Y; Sakamoto K; Ueno T; Hazama S; Ogihara H; Fujita Y; Hamamoto Y; Oka M; Iizuka N
Int J Oncol; 2015 Mar; 46(3):944-52. PubMed ID: 25524574
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of advanced hepatocellular carcinoma: a new stratification of Barcelona Clinic Liver Cancer stage C: results from a French multicenter study.
Adhoute X; Pénaranda G; Raoul JL; Blanc JF; Edeline J; Conroy G; Perrier H; Pol B; Bayle O; Monnet O; Beaurain P; Muller C; Castellani P; Bronowicki JP; Bourlière M
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):433-40. PubMed ID: 26695429
[TBL] [Abstract][Full Text] [Related]
40. Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients.
Chen CZ; Zhong JH; Qi YP; Zhang J; Huang T; Ma L; Li LQ; Peng T; Xiang BD
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33835138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
